Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 8NIH 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 3Gliosarcoma 2Glioblastoma 2Central Nervous System Neoplasms 2Breast Neoplasms, Male 2Waldenstrom Macroglobulinemia 1Somatostatinoma 1Sarcoma 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Osteosarcoma 1Mesothelioma, Malignant 1Meningioma 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Lung Neoplasms 1Leukemia, Lymphocytic, Chronic, B-Cell 1Kidney Neoplasms 1Insulinoma 1Immunoblastic Lymphadenopathy 1Glucagonoma 1

Interventions

Ifosfamide 19Doxorubicin 19Filgrastim 17Radiotherapy 13Vincristine 11Cyclophosphamide 11Etoposide 9Cisplatin 9Granulocyte Colony-Stimulating Factor 8Gene Expression Profiling 8Trabectedin 7Polymerase Chain Reaction 7Dactinomycin 6sargramostim 5etoposide phosphate 5Paclitaxel 5Mesna 5Chemotherapy, Adjuvant 4Brachytherapy 4pegfilgrastim 3Topotecan 3Microarray Analysis 3Irinotecan 3Immunohistochemistry 3Imatinib Mesylate 3Gemcitabine 3Dexrazoxane 3Base Sequence 3olaparib 2brostallicin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Sarcoma × Everolimus × Clear all
NCT01804374 2015-06-17

SERIO

Italian Sarcoma Group

Phase 2 Completed
38 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡